Compare PBI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBI | VCEL |
|---|---|---|
| Founded | 1920 | 1989 |
| Country | United States | United States |
| Employees | 6600 | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | N/A | 1996 |
| Metric | PBI | VCEL |
|---|---|---|
| Price | $15.67 | $33.27 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $13.00 | ★ $57.75 |
| AVG Volume (30 Days) | ★ 3.5M | 508.0K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $276,259,000.00 |
| Revenue This Year | N/A | $19.40 |
| Revenue Next Year | N/A | $18.24 |
| P/E Ratio | ★ $13.24 | $110.80 |
| Revenue Growth | N/A | ★ 16.45 |
| 52 Week Low | $8.95 | $28.95 |
| 52 Week High | $15.95 | $45.97 |
| Indicator | PBI | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 73.94 | 44.39 |
| Support Level | $10.96 | $30.12 |
| Resistance Level | N/A | $34.77 |
| Average True Range (ATR) | 0.57 | 2.16 |
| MACD | -0.05 | -0.11 |
| Stochastic Oscillator | 87.95 | 16.35 |
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.